UK investigates AstraZeneca's "weight gain" Seroquel ad
09 February 2010
Becky Debens
The UK pharmaceutical industry association's self regulatory body is investigating whether an advertisement for
AstraZeneca's antipsychotic Seroquel (quetiapine fumarate) has breached its advertising code.
The advert, run in the British Journal of Psychiatry in 2004, claimed Seroquel was...
Please Login to read the full article.
09 February 2010
Becky Debens
The advert, run in the British Journal of Psychiatry in 2004, claimed Seroquel was...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: House bill seeks cuts for health reform, but NIH would gain $1B
- US lawmakers want answers on excessive off-label antipsychotic use in nursing homes
- 2012 patent expiries will undermine pharma industry
- 'Confused' FDA panel splits on Alexza's inhaled antipsychotic
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
